Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kenny Misael Calvillo-Rodriguez"'
Autor:
Ana Carolina Martínez-Torres, Alejandra Reyes-Ruiz, Kenny Misael Calvillo-Rodriguez, Karla Maria Alvarez-Valadez, Ashanti C. Uscanga-Palomeque, Reyes S. Tamez-Guerra, Cristina Rodríguez-Padilla
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background IMMUNEPOTENT CRP (ICRP) can be cytotoxic to cancer cell lines. However, its widespread use in cancer patients has been limited by the absence of conclusive data on the molecular mechanism of its action. Here, we evaluated the mech
Externí odkaz:
https://doaj.org/article/0279c89d9d7f4fbbb3e61b1803cba312
Autor:
Kenny Misael Calvillo-Rodriguez, Cristina Rodríguez-Padilla, Alejandra Reyes-Ruiz, Ana Carolina Martínez-Torres
Publikováno v:
British Journal of Cancer
Background Cancer recurrence is a serious problem in breast cancer (BC) patients, and immunogenic cell death (ICD) has been proposed as a strategy to overcome this recurrence. IMMUNEPOTENT CRP (ICRP) acts as an immunomodulator and can be cytotoxic to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a5fc62c73a69232635eb94352483c2
http://europepmc.org/articles/PMC8039030
http://europepmc.org/articles/PMC8039030
Autor:
Alejandro González-Mora, Marco Rito-Palomares, Ana Carolina Martínez-Torres, Jorge Benavides, Kenny Misael Calvillo-Rodriguez, Jesús Hernández-Pérez
Publikováno v:
Pharmaceutics, Vol 13, Iss 2018, p 2018 (2021)
Pharmaceutics; Volume 13; Issue 12; Pages: 2018
Pharmaceutics
Pharmaceutics; Volume 13; Issue 12; Pages: 2018
Pharmaceutics
Cattle tick (Rhipicephalus microplus) represents a severe problem causing substantial economic losses, estimated in billions of dollars annually. Currently, chemical acaricides represent the most widely used control method. However, several problems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65008fbe01a3ccebbbae9635c2ab4cc8
https://www.mdpi.com/1999-4923/13/12/2018
https://www.mdpi.com/1999-4923/13/12/2018
Autor:
Reyes Tamez-Guerra, Kenny Misael Calvillo-Rodriguez, Cristina Rodríguez-Padilla, Ana Carolina Martínez-Torres, Karla Maria Alvarez-Valadez, Ashanti Concepción Uscanga-Palomeque, Alejandra Reyes-Ruiz
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Background IMMUNEPOTENT CRP (ICRP) can be cytotoxic to cancer cell lines. However, its widespread use in cancer patients has been limited by the absence of conclusive data on the molecular mechanism of its action. Here, we evaluated the mechanism of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f1c78dce46040536bdffbc1c5bba55
https://pubmed.ncbi.nlm.nih.gov/32660440
https://pubmed.ncbi.nlm.nih.gov/32660440
Autor:
Eva Lardé, Thomas Denèfle, Ana Carolina Martínez-Torres, Diana Caballero-Hernández, Hélène Merle-Béral, Ashanti Concepción Uscanga-Palomeque, Cristina Rodríguez-Padilla, Philippe Karoyan, Kenny Misael Calvillo-Rodriguez, Luis Gómez-Morales, Santos A. Susin
Publikováno v:
Cancer Science
Cancer Science, Wiley Open Access, 2019, 110 (1), pp.256-268. ⟨10.1111/cas.13885⟩
Cancer Science, Wiley Open Access, 2019, 110 (1), pp.256-268. ⟨10.1111/cas.13885⟩
International audience; T-cell acute lymphoblastic leukemia (T-ALL) has a poor prognosis derived from its genetic heterogeneity, which translates to a high chemoresistance. Recently, our workgroup designed thrombospondin-1-derived CD47 agonist peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd4b4f6c304371c9a5bd922ec9815e1
https://hal.sorbonne-universite.fr/hal-02364061/file/Uscanga-Palomeque_et_al-2019-Cancer_Science.pdf
https://hal.sorbonne-universite.fr/hal-02364061/file/Uscanga-Palomeque_et_al-2019-Cancer_Science.pdf
Autor:
Rodolfo Mendoza-Reveles, Ana Carolina Martínez-Torres, Kenny Misael Calvillo-Rodriguez, Luis Gómez-Morales, Diana Caballero-Hernández, Cristina Rodríguez-Padilla, Philippe Karoyan, Ashanti Concepción Uscanga-Palomeque
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Acute lymphocytic leukemia (ALL) is the most common pediatric cancer. Currently, treatment options for patients with relapsed and refractory ALL mostly rely on immunotherapies. However, hematological cancers are commonly associated with a low immunog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fba0dc4f859dd6cfaae41ff83c1ec92
https://doaj.org/article/261d1cf4997f46e4b9fccbb459ced051
https://doaj.org/article/261d1cf4997f46e4b9fccbb459ced051
Autor:
Kenny Misael Calvillo-Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez-Padilla, Ana Carolina Martínez-Torres, Daniel Scott-Algara
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cancer immunotherapies include monoclonal antibodies, cytokines, oncolytic viruses, cellular therapies, and other biological and synthetic immunomodulators. These are traditionally studied for their effect on the immune system’s role in eliminating
Externí odkaz:
https://doaj.org/article/5ad05fc728cf402aa91c595a4b53237e
Autor:
Kenny Misael Calvillo-Rodríguez, Rodolfo Mendoza-Reveles, Luis Gómez-Morales, Ashanti Concepción Uscanga-Palomeque, Philippe Karoyan, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women worldwide. Recent advances in the field of immuno-oncology demonstrate the beneficial immunostimulatory effects of the induction of immunogenic cell de
Externí odkaz:
https://doaj.org/article/cc3b36809cfe4e05b0941df64147e4b9